Archives
-
MEHP Activates AhR in Mouse Ovarian Follicles
2026-09-04
The 2024 Biology of Reproduction study identifies the aryl hydrocarbon receptor as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological blockade with CH 223191 partially restored follicle growth, estrogen production, and estrogen-responsive gene expression, providing a causal framework for interpreting AhR involvement in reproductive toxicology.
-
HNRNPU K181 Lactylation Rewires Serine Metabolism
2026-09-04
This Advanced Science study identifies HNRNPU lysine 181 lactylation as a lactate-responsive mechanism that stabilizes HNRNPU, preserves PHGDH mRNA regulation, and activates serine biosynthesis in cervical cancer. The work connects a non-histone post-translational modification to tumor metabolism and evaluates pharmacological interference with this axis, while also highlighting the need for careful validation of mechanism and specificity.
-
Oligo (dT) 25 Beads: Practical mRNA Guide
2026-09-03
Oligo (dT) 25 Beads support selective polyA tail mRNA capture from eukaryotic total RNA or cell and tissue lysates, simplifying magnetic separation before cDNA synthesis or mRNA elution. They should not be used as a universal total-RNA cleanup method or for unbiased recovery of non-polyadenylated transcripts.
-
Hexamethonium Bromide for Autonomic Signaling Studies
2026-09-03
Use Hexamethonium Bromide to isolate ganglionic contributions from vascular, cardiac, and baroreflex responses in neuronal and cardiovascular assays. A practical workflow combines fresh solution preparation, sex-stratified telemetry, controlled blockade, and troubleshooting based on quantitative hypertension findings.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-02
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at markedly lower concentrations than wild-type yeast. The system distinguished known and candidate TOR inhibitors from compounds such as Canagliflozin that showed no TOR-dependent growth phenotype, providing a practical framework for early-stage mechanism-focused screening.
-
MLN4924 Workflow for NAE and CRL Studies
2026-09-02
MLN4924 gives cancer biology research a mechanistically defined way to inhibit NAE, suppress cullin-RING ligase activity, and track substrate accumulation. This workflow connects fast biochemical target engagement with cell-cycle assays and carefully controlled extensions into FBXW7–SPT6–ΔNp63 studies and xenograft biomarker development.
-
Synthetic DEFB1 mRNA Limits Cryptosporidium Infection
2026-09-01
The reference study uses synthetic, co-transcriptionally capped DEFB1 mRNA to increase β-defensin 1 production in human intestinal cells and reduce Cryptosporidium parvum infection in vitro. Its design links delivery verification, host-protein induction, parasite quantification, and viability testing, providing a useful framework for host-directed therapy research.
-
Açaí Extracts: Hepatocyte Cytotoxicity and Induction
2026-09-01
Raichura and colleagues evaluated consumer-relevant açaí extracts in human hepatocytes and complementary transporter cells, distinguishing extract-dependent cytotoxicity from drug-metabolizing enzyme or transporter induction. The findings suggest that selected preparations can compromise hepatocyte viability without significantly increasing CYP or transporter expression, providing a useful framework for botanical-drug interaction assessment.
-
SGC-CBP30 and the Epigenetic Logic of LUAD
2026-08-31
Super-enhancer hijacking can create transcriptional dependencies that are difficult to resolve with genomic profiling alone. This thought-leadership guide connects the LINC01977–TGF-β/SMAD3 axis in early-stage lung adenocarcinoma with SGC-CBP30, a selective CREBBP/EP300 bromodomain inhibitor, and outlines a disciplined path from mechanistic hypothesis to translational validation.
-
Ac-YVAD-CMK: Mapping Pyroptosis in Liver
2026-08-31
Ac-YVAD-CMK is a selective, irreversible caspase-1 inhibitor for dissecting pyroptosis, cytokine maturation, and liver inflammation. This article presents a causal assay framework that separates Kupffer-cell membrane repair from downstream inflammasome activity.
-
Vorinostat for HDAC Inhibition Workflows
2026-08-30
Build reproducible HDAC-inhibition experiments with Vorinostat, from DMSO stock preparation through chromatin, viability, and apoptosis readouts. The workflow also positions this benchmark compound against M344 for cancer biology research and helps distinguish cytostatic effects from mitochondrial cell death.
-
TBST for Antibody Assays: Workflow and Troubleshooting
2026-08-29
TBST combines Tris-buffered saline with Tween 20 to support lower-background Western blot, immunofluorescence, immunohistochemistry, and immunocytochemistry workflows. This practical guide connects buffer selection with a published uPAR·uPA inhibitor study, showing how disciplined washing and orthogonal readouts can strengthen conclusions about antibody-based assays.
-
Full-Length αvβ3 Integrin Conformations by Cryo-EM
2026-08-28
This cryo-EM study resolves an unusually broad set of full-length human αvβ3 integrin conformations in apo and ligand-bound states. Its dynamic structural model clarifies how intermediate states and inhibitor-specific recognition may influence integrin drug design, while also defining important limits for translating purified-protein structures into cellular mechanisms.
-
Baicalein: Mechanism, Evidence, and Research Use
2026-08-28
Baicalein, also called 5,6,7-trihydroxy-2-phenylchromen-4-one, is a flavonoid research compound associated with 12-lipoxygenase inhibition, apoptosis studies, and inflammation pathway modulation. Its product specifications support controlled biochemical and cell-based workflows, but they do not establish clinical efficacy or direct neuroprotective activity.
-
EGTA for Calcium Signaling Workflows
2026-08-27
EGTA, or egtazic acid, provides a practical way to test whether calcium availability drives neuronal, endothelial, or cell-death phenotypes. This guide connects selective calcium chelation with patch-clamp pharmacology, neuroprotection experiments, apoptosis assays, and troubleshooting for reproducible workflows.